Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Last updated: August 6, 2025
Sponsor: Eye Research Foundation, Inc.
Overall Status: Completed

Phase

4

Condition

Blepharitis

Treatment

Moxidectin 2 MG Oral Tablet

Placebo

Clinical Study ID

NCT06795165
MOX-001
  • Ages > 18
  • All Genders

Study Summary

A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Active blepharitis with collarettes

Exclusion

Exclusion Criteria:

  • Other clinically significant eye disease

Study Design

Total Participants: 24
Treatment Group(s): 2
Primary Treatment: Moxidectin 2 MG Oral Tablet
Phase: 4
Study Start date:
February 02, 2025
Estimated Completion Date:
June 15, 2025

Connect with a study center

  • Eye Research Foundation, Inc.

    Newport Beach, California 92663
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.